Generated by AI
Tempest Therapeutics Inc. is a clinical-stage biotechnology company focused on developing cancer therapies through targeted and immune-mediated mechanisms. The company’s current pipeline centers on small molecule and cell therapy programs designed to address multiple oncology indications, including solid tumors and hematologic cancers. Its portfolio includes advanced investigational candidates that aim to modulate tumor biology, enhance anti-tumor immune responses, and broaden the reach of next-generation cell therapy approaches. Tempest Therapeutics also works with partners on certain clinical programs, reflecting a business model centered on drug development, clinical research, and translational oncology. Based in Brisbane, California, Tempest Therapeutics Inc. operates within the biopharmaceutical sector as a research-driven company advancing experimental treatments toward clinical evaluation.
Website2000 Sierra Point Parkway
Brisbane, CA, 94005
United States
The latest articles about TPST.
Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.
Summary of Nov 16's posts. Generated by AI.
Summary of Sep 16's posts. Generated by AI.
Summary of Apr 10's posts. Generated by AI.
Summary of Sep 17's posts. Generated by AI.
Investors talking about TPST also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.